Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer, and especially aggressive lymphoma. The company was originally established in 1999 as a spin-off from Lund University. The business is located in Sweden, where research is conducted in-house but also through international partners. The company is headquartered in Lund.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Avanza Pension | 5,87 | 5,87 | 2025-09-26 |
| Valcuria Holding AB | 3,70 | 3,70 | 2025-09-26 |
| Hartmut Wiese | 2,53 | 2,53 | 2025-09-26 |
| Hans Mandahl | 1,65 | 1,65 | 2025-09-26 |
| Ulf Stahlin | 1,21 | 1,21 | 2025-09-26 |
| Håkan Svensson | 1,14 | 1,14 | 2025-09-26 |
| Gerhard Dal | 1,11 | 1,11 | 2025-09-26 |
| Per Vasilis | 1,11 | 1,11 | 2025-09-26 |
| Patrik Steve-Erik Jonsson | 1,03 | 1,03 | 2025-09-26 |
| Erik Boström | 1,00 | 1,00 | 2025-09-26 |
2025-11-11 Delårsrapport 2025-Q3
2026-02-10 Bokslutskommuniké 2025
